Remote superficial femoral artery endarterectomy and distal aSpire stenting: multicenter medium-term results

Rosenthal, David; Martin, John D.; Schubart, Peter; Wellons, Eric D.; Shuler, Frederick W.; Levitt, Adam

doi:10.1016/j.jvs.2004.03.038

Cited by 31 publications

(23 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…RE with distal end point stenting is a less invasive alternative to bypass in patients with complete longsegment SFA occlusion. [16][17][18][19] Documented advantages of RE are reduced hospitalization, preservation of bypass options, decreased morbidity, and lower incidence of limbthreatening ischemia when RE is unsuccessful. Notwithstanding advanced endovascular techniques and the availability of new devices, which have allowed treatment of an increasing number of patients with femoropopliteal occlusive disease, long-term results remain to be defined in prospective cohorts.…”

Section: Discussionmentioning

confidence: 99%

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Gabrielli

Rosati

Vitale

et al. 2012

Journal of Vascular Surgery

View full text Add to dashboard Cite

RE is a safe, effective, and durable procedure for TASC-II D lesions. Our data demonstrate a significantly higher primary, assisted primary, and secondary patency of RE vs ENDO procedures. Furthermore, overall secondary patency rates remain within the standard limits, although preoperative CLI and dyslipidemia continue to be associated with worse outcomes. Taken together, these data suggest that RE should be considered better than an endovascular procedure in SFA long-segment occlusion treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Gabrielli

Rosati

Vitale

et al. 2012

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…To treat moderate and severely calcified lesions in SFA and/or PA it is quite safe and effective to apply S/TH when a distal embolic protection device is used. 13-20…”

Section: Resultsmentioning

confidence: 99%

Better treatment option in chronic superficial femoral artery occlusive disease: comparison of methods (meta-analysis)

Starodubtsev¹,

Karpenko²,

Ленько³

et al. 2019

J Cardiovasc Thorac Res

View full text Add to dashboard Cite

Introduction: The objective is to evaluate the frequency of primary obstruction events (PrO) during one-year follow-up after performing excisional atherectomy with the SilverHawk/TurboHawk atherectomy device (S/TH) or remote superficial femoral artery endarterectomy (RSFAE) in patients with the chronic superficial femoral artery occlusive disease (СSFAOD). Methods: We included all randomized clinical trials (RCTs) and not-RCTs concerning the treatment of patients with СSFAOD after S/TH and RSFAE without duration. Results: Twenty-nine items (1990-2017) were discovered; 27 articles on the levels of evidence were included in qualitative synthesis; 9 studies (meta-analysis) were included in quantitative synthesis. The results of 2762 patients’ treatment were summed up in our analysis (1422 patients S/TH; 1340 patients RSFAE). All included reports were at low risk of bias. According to the criterion "frequency of PrO" during one-year follow-up, the pooled Hazard Ratios indicate significant favours of S/TH if compared it with RSFAE (HR= 0.66 (0.57 to 0.76, P < 0.00001), I2 = 9%). Conclusion: Our study showed that S/TH with the SpiderFX device (distal embolic protection) are safe and effective treatment option for short lesion (<15 cm) in patients with СSFAOD. The usage of S/TH methods significantly reduced number of PrO if compared it with RSFAE. In long-segment lesion (>15 cm) in patients with СSFAOD, RSFAE may be considered better than an endovascular procedure. But still it is necessary to conduct well-planned randomized studies to determine effectiveness and safety of the compared methods (S/TH and RSFAE) in patients with long-segment lesion (>15 cm).

show abstract

“…Prosthetic stent-grafts, mostly utilizing ePTFE, have been shown to have poor 1-year patency rates. 4,5 Other designs employed saphenous vein as a lining, but patency rates were poor, and other logistical issues arose due to limited lumen diameter and concerns about tissue thickness.…”

Section: Discussionmentioning

confidence: 99%

Fatigue and In Vivo Validation of a Peritoneum-Lined Self-Expanding Nitinol Stent-Graft

Bastijanic¹,

Etscheidt²,

Sattiraju³

et al. 2014

Journal of Endovascular Therapy

View full text Add to dashboard Cite

.P urpose: To assess the fatigue and in vivo performance of a new stent-graft incorporating bovine peritoneum lining that is designed for application in peripheral vascular occlusive disease. Methods: Bovine peritoneum-lined stent-grafts were subjected to accelerated in vitro pulsatile fatigue and axial/torsional fatigue testing designed to simulate 10 years of physiological strain on the devices. At specified times the devices were evaluated for stent fracture, suture failure, or tissue tearing. Seven dogs underwent bilateral common iliac artery (CIA) balloon angioplasty injury with unilateral placement of the peritoneum-lined stent-graft. Angiography and intravascular ultrasound were performed prior to treatment, after treatment, and prior to sacrifice at 30 days. Vessels were perfusion fixed and histologically evaluated at 5 regions: above stent, proximal stent, mid stent, distal stent, and below stent. Results: No evidence of stent, suture, or tissue failure was present during or after pulsatile and axial/torsional fatigue testing. At 3060.3 days after implantation, all vessels were patent. The average lumen area at explantation across stented vessels was 25.45 mm ). The mean neointimal area in peritoneum-lined stents was 2.0261.52 mm 2 , with a neointima:media ratio of 1.0360.50. These values were significantly lower in the above and below stent areas than in the stented regions, but there was no difference in either measure within the proximal, mid, or distal stent. Conclusion: The custom-designed peritoneum-lined stent-graft is promising for clinical peripheral applications due to its ability to resist relevant long-term physiological stresses and outstanding short-term patency rates in canine implantations.

show abstract

Remote superficial femoral artery endarterectomy and distal aSpire stenting: multicenter medium-term results

Cited by 31 publications

References 21 publications

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Better treatment option in chronic superficial femoral artery occlusive disease: comparison of methods (meta-analysis)

Fatigue and In Vivo Validation of a Peritoneum-Lined Self-Expanding Nitinol Stent-Graft

Contact Info

Product

Resources

About